Evidence map›Paper›PMID 42232528›Full record

ReviewBeilstein journal of nanotechnology2026

Environmental applications of silver nanoparticles: state-of-the-art review and emerging trends.

Soni Prajapati, Akash Kumar, Ranjana Singh

Abstract readReview
In one paragraph

Review in Beilstein journal of nanotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Soni PrajapatiDepartment of Biochemistry, King George's Medical University, Lucknow, India.ORCID https://orcid.org/0009-0007-8983-9185
Akash KumarAcademy of Scientific and Innovative Research, Ghaziabad, India.
Ranjana SinghDepartment of Biochemistry, King George's Medical University, Lucknow, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Silver nanoparticles (AgNPs) possess inherent catalytic, antimicrobial, and optical properties, making them a strong candidate for environmental applications in water, air, and soil. Indeed, various reviews are available, though a significant gap persists in addressing all environmental pollutants. This review comprehensively and critically analyses the advancement in AgNP research spanning from synthesis and characterisation to practical deployment and ecotoxicological assessment. The AgNP-based systems are evaluated regarding antimicrobial disinfection, adsorptive and catalytic/photocatalytic removal of persistent organic pollutants, and integration into antifouling nanofiltration and ultrafiltration membrane technologies used for management of water pollutants. In addition, AgNPs-assisted nanosystems in fibrous filter membranes and photocatalytic composite coatings for the removal of volatile organic compounds, particulate matter, and gaseous pollutants are reviewed. Furthermore, AgNP applications for heavy metal immobilisation, organic pollutant degradation, plant disease management, and growth promotion are assessed alongside their ecotoxicological implications. Besides remediation, environmental monitoring capabilities of AgNP-based sensing platforms are systematically reviewed across five transduction modalities, including colourimetric/UV-vis LSPR, SERS, electrochemical, fluorometric, and gas sensing, covering a broad range of analytes considered as environmental pollutants. Key challenges, including nanoparticle aggregation, long-term colloidal instability, synthesis irreproducibility, ecotoxicological risks arising from Ag

Indexed as

AgNPsair applicationenvironmental pollutantssoil applicationssynthesiswater application

Identifiers

PMID42232528
PMCPMC13224055

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.